<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">sechenov</journal-id><journal-title-group><journal-title xml:lang="en">Sechenov Medical Journal</journal-title><trans-title-group xml:lang="ru"><trans-title>Сеченовский вестник</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2218-7332</issn><issn pub-type="epub">2658-3348</issn><publisher><publisher-name>Сеченовский Университет</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.47093/2218-7332.2022.13.1.24-33</article-id><article-id custom-type="elpub" pub-id-type="custom">sechenov-453</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>PATHOLOGICAL PHYSIOLOGY</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ПАТОЛОГИЧЕСКАЯ ФИЗИОЛОГИЯ</subject></subj-group></article-categories><title-group><article-title>Creatine phosphate preconditioning reduces ischemiareperfusion injury in isolated rat heart</article-title><trans-title-group xml:lang="ru"><trans-title>Прекондиционирование креатин фосфатом уменьшает ишемическо-реперфузионное повреждение изолированного сердца крысы</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6862-9791</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Гаджиева</surname><given-names>Л. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Gadjieva</surname><given-names>L. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Гаджиева Луиза Абдурашидовна, соискатель ученой степени канд. мед. наук, врач-терапевт отдела экстренной медицинской помощи</p><p>ул. Пушкина, д. 29а–31, г. Махачкала, 367000</p></bio><bio xml:lang="en"><p>Louisa A. Gadjieva, applicant for Cand. of Sci. (Medicine), internist, urgent medical aid department</p><p>29а–31, Pushkina str., Makhachkala, 367000</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1574-477X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Болевич</surname><given-names>С. Б.</given-names></name><name name-style="western" xml:lang="en"><surname>Bolevich</surname><given-names>S. B.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Болевич Сергей Бранкович, д-р мед. наук, профессор, заведующий кафедрой патологии человека</p><p>ул. Трубецкая, д. 8, стр. 2, г. Москва, 119991</p></bio><bio xml:lang="en"><p>Sergey B. Bolevich, Dr. of Sci. (Medicine), Professor, Head of the Human Pathology Department</p><p>8/2, Trubetskaya str., Moscow, 119991</p></bio><email xlink:type="simple">bolevich2011@yandex.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0071-8376</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Яковлевич</surname><given-names>В.</given-names></name><name name-style="western" xml:lang="en"><surname>Jakovlevich</surname><given-names>V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Яковлевич Владимир, д-р мед. наук, профессор, декан факультета медицинских наук</p><p>ул. Трубецкая, д. 8, стр. 2, г. Москва, 119991</p><p>ул. Светозара Марковича, д. 69, Крагуевац, 34000</p></bio><bio xml:lang="en"><p>Vladimir Jakovljevic, MD, PhD, Professor, Dean of the Faculty of Medical Sciences</p><p>8/2, Trubetskaya str., Moscow, 119991</p><p>69, Svetozar Markovic str., Kragujevac, 34000</p></bio><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0886-8878</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Омаров</surname><given-names>И. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Omarov</surname><given-names>I. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Омаров Исрапил Алисултанович, канд. мед. наук, врач – стоматолог-ортопед</p><p>Смоленская наб., д. 2, корп. 2, г. Москва, 121099</p></bio><bio xml:lang="en"><p>Israpil A. Omarov, Cand. of Sci. (Medicine), orthopedic dentist, Medical and health center</p><p>2, bld. 2, Smolenskaja quay, Moscow, 121099</p></bio><xref ref-type="aff" rid="aff-4"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4290-2665</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ордашев</surname><given-names>Х. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Ordashev</surname><given-names>H. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Ордашев Хасан Алиевич, канд. мед. наук, доцент, заведующий кафедрой хирургической стоматологии и челюстно-лицевой хирургии с усовершенствованием врачей</p><p>пл. Ленина, д. 1, г. Махачкала, 367000</p></bio><bio xml:lang="en"><p>Hasan A. Ordashev, Cand. of Sci. (Medicine), Associate Professor, Head of the Department of Surgical Dentistry and Maxillofacial Surgery with advanced training for doctors</p><p>1, Lenin Square, Makhachkala, 367000</p></bio><xref ref-type="aff" rid="aff-5"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2135-1662</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Карташова</surname><given-names>М. К.</given-names></name><name name-style="western" xml:lang="en"><surname>Kartashova</surname><given-names>M. K.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Карташова Мария Константиновна, студентка 6-го курса лечебного факультета</p><p>ул. Трубецкая, д. 8, стр. 2, г. Москва, </p></bio><bio xml:lang="en"><p>Maria K. Kartashova, 6th year student of Medical Faculty</p><p>8/2, Trubetskaya str., Moscow, 119991</p></bio><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФКУЗ «Медико-санитарная часть Министерства внутренних дел Российской Федерации по Республике Дагестан»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Medical and Sanitary Unit of the Ministry of Internal Affairs of Russia in the Republic of Dagestan</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФГАОУ ВО «Первый Московский государственный медицинский университет им. И.М. Сеченова» Минздрава России (Сеченовский Университет)</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Sechenov First Moscow State Medical University (Sechenov University)</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>ФГАОУ ВО «Первый Московский государственный медицинский университет&#13;
им. И.М. Сеченова» Минздрава России (Сеченовский Университет); Крагуевацкий университет</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Sechenov First Moscow State Medical University (Sechenov University); University of Kragujevac</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-4"><aff xml:lang="ru"><institution>ФГЛПУ «Лечебно-оздоровительный центр МИД РФ»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Health-Related Center of Ministry of External Affairs of Russian Federation</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-5"><aff xml:lang="ru"><institution>ФГБОУ ВО «Дагестанский государственный медицинский университет» Минздрава России</institution><country>Дания</country></aff><aff xml:lang="en"><institution>Dagestan State Medical Univesity</institution><country>Denmark</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2022</year></pub-date><pub-date pub-type="epub"><day>25</day><month>10</month><year>2021</year></pub-date><volume>13</volume><issue>1</issue><elocation-id>24–33</elocation-id><permissions><copyright-statement>Copyright &amp;#x00A9; Gadjieva L.A., Bolevich S.B., Jakovlevich V., Omarov I.A., Ordashev H.A., Kartashova M.K., 2021</copyright-statement><copyright-year>2021</copyright-year><copyright-holder xml:lang="ru">Гаджиева Л.А., Болевич С.Б., Яковлевич В., Омаров И.А., Ордашев Х.А., Карташова М.К.</copyright-holder><copyright-holder xml:lang="en">Gadjieva L.A., Bolevich S.B., Jakovlevich V., Omarov I.A., Ordashev H.A., Kartashova M.K.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.sechenovmedj.com/jour/article/view/453">https://www.sechenovmedj.com/jour/article/view/453</self-uri><abstract><p>Aim. To study the effect of simultaneous administration of creatine phosphate immediately before ischemia on cardiodynamic parameters and biomarkers of oxidative stress in the coronary venous blood flow during retrograde perfusion in an isolated rat heart.Materials and methods. 20 Wistar albino rats were divided into 2 groups: group 1 (control) and group 2 (experimental), 10 rats per group. Cannulation and retrograde perfusion of aorta of an isolated rat heart with Krebs–Henseleit buffered solution by Landendorff was performed. Both groups underwent ischemia-reperfusion injury, which included global ischemia for 20 minutes followed by reperfusion for 30 minutes. The group 2 (experimental) was preconditioned with creatine phosphate at a dose of 0.2 mmol/l for 5 min before ischemia. We registered cardiodynamic parameters and indicators of oxidative stress at the point of stabilization, at the 1st and 30th minutes of reperfusion.Results. With the impact of creatine phosphate at the 30th minute of reperfusion in the group 2 in comparison with group 1, there was found an increase in the maximum and minimum speed of pressure elevation in the left ventricle (1.7 and 1.9 times, respectively), and of systolic and diastolic pressure in the left ventricle (1.5 and 1.6 times, respectively). Biomarkers of oxidative stress (lipid peroxidation index, nitrites, superoxide anion radical and hydrogen peroxide) were also statistically significantly lower in the group 2 after the 1st minute of reperfusion (by 1.2 times, by 1.4 times, by 2.8 times and 1.9 times, respectively), and after the 30th minute (1.3 times, 2.1 times, 1.9 times and 2.1 times, respectively).Conclusion. The administration of creatine phosphate into the coronary flow 5 minutes before the onset of ischemia has a protective effect on myocardial contractility. Reduction of oxidative stress and damage can be considered as a protective effect of creatine phosphate.</p></abstract><trans-abstract xml:lang="ru"><p>Цель. Изучить влияние однократного введения креатин фосфата (КФ) непосредственно перед ишемией на кардиодинамические параметры и маркеры окислительного стресса в коронарном венозном оттоке ретроградно перфузированного изолированного сердца крысы.Материалы и методы. 20 крыс линии Wistar albino были разделены на 2 группы: контрольную (К) и экспериментальную (Э), по 10 в каждой. Аорту изолированного сердца крысы канюлировали и ретроградно перфузировали раствором Кребса – Хензелейта по Лангердорфу. Обе группы подвергались ишемическо-реперфузионному повреждению, которое включало глобальную ишемию в течение 20 минут, а затем реперфузию в течение 30 минут. В группе Э проводилось прекондиционирование КФ в дозе 0,2 ммоль/л в течение 5 мин перед ишемией. Регистрировались кардиодинамические параметры и показатели окислительного стресса в точке стабилизации, на 1-й и 30-й минутах реперфузии.Результаты. В группе Э по сравнению с группой К на 30-й минуте реперфузии отмечены статистически значимо более высокие значения кардиодинамических показателей: максимальной и минимальной скорости повышения давления в левом желудочке (в 1,7 и в 1,9 раза соответственно), систолического и диастолического давления в левом желудочке (в 1,5 и в 1,6 раза соответственно). Биомаркеры окислительного стресса (индекс перекисного окисления липидов, нитриты, супероксидный анион радикал и перекись водорода) также были статистически значимо ниже в группе Э как после 1-й минуты реперфузии (в 1,2, 1,4, 2,8 и 1,9 раза соответственно), так и после 30-й минуты (в 1,3, 2,1, 1,9 и 2,1 раза соответственно).Заключение. Введение КФ в коронарный кровоток за 5 минут до индукции ишемии оказывает защитное действие на сократительную способность миокарда. В качестве механизма протективного действия КФ может рассматриваться уменьшение окислительного стресса и повреждения.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>креатин фосфат</kwd><kwd>прекондиционирование</kwd><kwd>ишемия / реперфузионное повреждение</kwd><kwd>окислительный стресс</kwd><kwd>кардиодинамика</kwd><kwd>изолированное крысиное сердце</kwd><kwd>техника Лангендорфа</kwd></kwd-group><kwd-group xml:lang="en"><kwd>creatine phosphate</kwd><kwd>preconditioning</kwd><kwd>ischemia/reperfusion injury</kwd><kwd>oxidative stress</kwd><kwd>cardiodynamics</kwd><kwd>isolated rat heart</kwd><kwd>Langendorff technique</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Valikeserlis I., Athanasiou A.A., Stakos D. Cellular mechanisms and pathways in myocardial reperfusion injury. Coron Artery Dis. 2021 Sep 1; 32(6): 567–577. https://doi.org/10.1097/MCA.0000000000000997. PMID: 33471478</mixed-citation><mixed-citation xml:lang="en">Valikeserlis I., Athanasiou A.A., Stakos D. Cellular mechanisms and pathways in myocardial reperfusion injury. Coron Artery Dis. 2021 Sep 1; 32(6): 567–577. https://doi.org/10.1097/MCA.0000000000000997. PMID: 33471478</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">DePasquale E.C., Ardehali A. Primary graft dysfunction in heart transplantation. Curr Opin Organ Transplant. 2018; 23(3): 286–294. https://doi.org/10.1097/MOT.0000000000000523</mixed-citation><mixed-citation xml:lang="en">DePasquale E.C., Ardehali A. Primary graft dysfunction in heart transplantation. Curr Opin Organ Transplant. 2018; 23(3): 286–294. https://doi.org/10.1097/MOT.0000000000000523</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Cai W.B., Zhao Y.J., Liu L., et al. Redox environment metabolomic evaluation (REME) of the heart after myocardial ischemia/ reperfusion injury. Free Radic Biol Med. 2021 Sep; 173: 7–18. https://doi.org/10.1016/j.freeradbiomed.2021.06.033. Epub 2021 Jul 9. PMID: 34252540</mixed-citation><mixed-citation xml:lang="en">Cai W.B., Zhao Y.J., Liu L., et al. Redox environment metabolomic evaluation (REME) of the heart after myocardial ischemia/reperfusion injury. Free Radic Biol Med. 2021 Sep; 173: 7–18. https://doi.org/10.1016/j.freeradbiomed.2021.06.033. Epub 2021 Jul 9. PMID: 34252540</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Lu C., Liu L., Chen S., et al. Azathioprine pretreatment ameliorates myocardial ischaemia reperfusion injury in diabetic rats by reducing oxidative stress, apoptosis, and inflammation. Clin Exp Pharmacol Physiol. 2021 Dec; 48(12): 1621–1632. https://doi.org/10.1111/1440-1681.13569. Epub 2021 Aug 22. PMID: 34370882</mixed-citation><mixed-citation xml:lang="en">Lu C., Liu L., Chen S., et al. Azathioprine pretreatment ameliorates myocardial ischaemia reperfusion injury in diabetic rats by reducing oxidative stress, apoptosis, and inflammation. Clin Exp Pharmacol Physiol. 2021 Dec; 48(12): 1621–1632. https:// doi.org/10.1111/1440-1681.13569. Epub 2021 Aug 22. PMID: 34370882</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Murry C.E., Jennings R.B., Reimer K.A. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation. 1986 Nov; 74(5): 1124–1136. https://doi.org/10.1161/01.cir.74.5.1124. PMID: 3769170</mixed-citation><mixed-citation xml:lang="en">Murry C.E., Jennings R.B., Reimer K.A. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation. 1986 Nov; 74(5): 1124–1136. https://doi.org/10.1161/01.cir.74.5.1124. PMID: 3769170</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Granfeldt A., Lefer D.J., Vinten-Johansen J. Protective ischaemia in patients: preconditioning and postconditioning. Cardiovasc Res. 2009 Jul 15; 83(2): 234–246. https://doi.org/10.1093/cvr/cvp129. Epub 2009 Apr 27. PMID: 19398470</mixed-citation><mixed-citation xml:lang="en">Granfeldt A., Lefer D.J., Vinten-Johansen J. Protective ischaemia in patients: preconditioning and postconditioning. Cardiovasc Res. 2009 Jul 15; 83(2): 234–246. https://doi.org/10.1093/cvr/cvp129. Epub 2009 Apr 27. PMID: 19398470</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Caricati-Neto A., Errante P.R., Menezes-Rodrigues F.S. Recent advances in pharmacological and non-pharmacological strategies of cardioprotection. Int J Mol Sci. 2019 Aug 16; 20(16): 4002. https://doi.org/10.3390/ijms20164002. PMID: 31426434</mixed-citation><mixed-citation xml:lang="en">Caricati-Neto A., Errante P.R., Menezes-Rodrigues F.S. Recent advances in pharmacological and non-pharmacological strategies of cardioprotection. Int J Mol Sci. 2019 Aug 16; 20(16): 4002. https://doi.org/10.3390/ijms20164002. PMID: 31426434</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Roth S., Torregroza C., Feige K., et al. Pharmacological conditioning of the heart: an update on experimental developments and clinical implications. Int J Mol Sci. 2021 Mar 3; 22(5): 2519. https://doi.org/10.3390/ijms22052519. PMID: 33802308; PMCID: PMC7959135</mixed-citation><mixed-citation xml:lang="en">Roth S., Torregroza C., Feige K., et al. Pharmacological conditioning of the heart: an update on experimental developments and clinical implications. Int J Mol Sci. 2021 Mar 3; 22(5): 2519. https://doi.org/10.3390/ijms22052519. PMID: 33802308; PMCID: PMC7959135</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Gaddi A.V., Galuppo P., Yang J. Creatine phosphate administration in cell energy impairment conditions: A summary of past and present research. Heart Lung Circ. 2017 Oct; 26(10): 1026–1035. https://doi.org/10.1016/j.hlc.2016.12.020. Epub 2017 Mar 14. PMID: 28392102</mixed-citation><mixed-citation xml:lang="en">Gaddi A.V., Galuppo P., Yang J. Creatine phosphate administration in cell energy impairment conditions: A summary of past and present research. Heart Lung Circ. 2017 Oct; 26(10): 1026–1035. https://doi.org/10.1016/j.hlc.2016.12.020. Epub 2017 Mar 14. PMID: 28392102</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Говорушкина Н.С., Болевич С.Б., Яковлевич В. и др. Влияние соединения MK-801, глутамата и глицина через модуляцию N-метил-D-аспартатных рецепторов на изолированное сердце крысы. Сеченовский вестник. 2020; 11(1): 15–25. https://doi.org/10.47093/2218-7332.2020.11.1.15-25</mixed-citation><mixed-citation xml:lang="en">Govorushkina N.S., Bolevich S.B., Jakovlevich V., et al. Vliyanie soedineniya MK-801, glutamata i glitsina cherez modulyatsiyu N-metil-D-aspartatnykh retseptorov na izolirovannoe serdtse krysy [The influence of MK-801, glutamate and glycine via the modulation of N-methyl-D-aspartate receptors on isolated rat heart]. Sechenov Medical Journal. 2020; 11(1): 15–25. https://doi.org/10.47093/2218-7332.2020.11.1.15-2</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Qaed E., Wang J., Almoiliqy M., et al. Phosphocreatine improves cardiac dysfunction by normalizing mitochondrial respiratory function through JAK2/STAT3 signaling pathway in vivo and in vitro. Oxid Med Cell Longev. 2019 Nov 30; 2019: 6521218. https://doi.org/10.1155/2019/6521218. PMID: 31885809</mixed-citation><mixed-citation xml:lang="en">Qaed E., Wang J., Almoiliqy M., et al. Phosphocreatine improves cardiac dysfunction by normalizing mitochondrial respiratory function through JAK2/STAT3 signaling pathway in vivo and in vitro. Oxid Med Cell Longev. 2019 Nov 30; 2019: 6521218. https://doi.org/10.1155/2019/6521218. PMID: 31885809</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Kalogeris T., Baines C.P., Krenz M., Korthuis R.J. Cell biology of ischemia/reperfusion injury. Int Rev Cell Mol Biol. 2012; 298: 229–317. https://doi.org/10.1016/B978-0-12-394309-5.00006-7. PMID: 22878108</mixed-citation><mixed-citation xml:lang="en">Kalogeris T., Baines C.P., Krenz M., Korthuis R.J. Cell biology of ischemia/reperfusion injury. Int Rev Cell Mol Biol. 2012; 298: 229–317. https://doi.org/10.1016/B978-0-12-394309-5.00006-7. PMID: 22878108</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Sharov V.G., Afonskaya N.I., Ruda M.Y., et al. Protection of ischemic myocardium by exogenous phosphocreatine (neoton): pharmacokinetics of phosphocreatine, reduction of infarct size, stabilization of sarcolemma of ischemic cardiomyocytes, and antithrombotic action. Biochem Med Metab Biol. 1986 Feb; 35(1): 101–114. https://doi.org/10.1016/0885-4505(86)90064-2. PMID: 3778674</mixed-citation><mixed-citation xml:lang="en">Sharov V.G., Afonskaya N.I., Ruda M.Y., et al. Protection of ischemic myocardium by exogenous phosphocreatine (neoton): pharmacokinetics of phosphocreatine, reduction of infarct size, stabilization of sarcolemma of ischemic cardiomyocytes, and antithrombotic action. Biochem Med Metab Biol. 1986 Feb; 35(1): 101–114. https://doi.org/10.1016/0885-4505(86)90064-2. PMID: 3778674</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang W., Zhang H., Xing Y. Protective effects of phosphocreatine administered post-treatment combined with ischemic postconditioning on rat hearts with myocardial ischemia/reperfusion injury. J Clin Med Res. 2015 Apr; 7(4): 242–247. https://doi.org/10.14740/jocmr2087w. Epub 2015 Feb 9. PMID: 25699120</mixed-citation><mixed-citation xml:lang="en">Zhang W., Zhang H., Xing Y. Protective effects of phosphocreatine administered post-treatment combined with ischemic postconditioning on rat hearts with myocardial ischemia/reperfusion injury. J Clin Med Res. 2015 Apr; 7(4): 242–247. https://doi.org/10.14740/jocmr2087w. Epub 2015 Feb 9. PMID: 25699120</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Prabhakar G., Vona-Davis L., Murray D., et al. Phosphocreatine restores high-energy phosphates in ischemic myocardium: implication for off-pump cardiac revascularization. J Am Coll Surg. 2003 Nov; 197(5): 786–791. https://doi.org/10.1016/j.jamcollsurg.2003.05.001. PMID: 14585415</mixed-citation><mixed-citation xml:lang="en">Prabhakar G., Vona-Davis L., Murray D., et al. Phosphocreatine restores high-energy phosphates in ischemic myocardium: implication for off-pump cardiac revascularization. J Am Coll Surg. 2003 Nov; 197(5): 786–791. https://doi.org/10.1016/j.jamcollsurg.2003.05.001. PMID: 14585415</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Kim J.S., Jin Y., Lemasters J.J. Reactive oxygen species, but not Ca2+ overloading, trigger pH- and mitochondrial permeability transition-dependent death of adult rat myocytes after ischemiareperfusion. Am J Physiol Heart Circ Physiol. 2006 May; 290(5): H2024–2034. https://doi.org/10.1152/ajpheart.00683.2005. Epub 2006 Jan 6. PMID: 16399872</mixed-citation><mixed-citation xml:lang="en">Kim J.S., Jin Y., Lemasters J.J. Reactive oxygen species, but not Ca2+ overloading, trigger pH- and mitochondrial permeability transition-dependent death of adult rat myocytes after ischemiareperfusion. Am J Physiol Heart Circ Physiol. 2006 May; 290(5): H2024–2034. https://doi.org/10.1152/ajpheart.00683.2005. Epub 2006 Jan 6. PMID: 16399872</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Robinson L.A., Braimbridge M.V., Hearse D.J. Creatine phosphate: an additive myocardial protective and antiarrhythmic agent in cardioplegia. J Thorac Cardiovasc Surg. 1984 Feb; 87(2): 190–200. PMID: 6694410</mixed-citation><mixed-citation xml:lang="en">Robinson L.A., Braimbridge M.V., Hearse D.J. Creatine phosphate: an additive myocardial protective and antiarrhythmic agent in cardioplegia. J Thorac Cardiovasc Surg. 1984 Feb; 87(2): 190–200. PMID: 6694410</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Tokarska-Schlattner M., Epand R.F., Meiler F., et al. Phosphocreatine interacts with phospholipids, affects membrane properties and exerts membrane-protective effects. PLoS One. 2012; 7(8): e43178. https://doi.org/10.1371/journal.pone.0043178. Epub 2012 Aug 17. PMID: 22912820</mixed-citation><mixed-citation xml:lang="en">Tokarska-Schlattner M., Epand R.F., Meiler F., et al. Phosphocreatine interacts with phospholipids, affects membrane properties and exerts membrane-protective effects. PLoS One. 2012; 7(8): e43178. https://doi.org/10.1371/journal.pone.0043178. Epub 2012 Aug 17. PMID: 22912820</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Zucchi R., Poddighe R., Limbruno U., et al. Protection of isolated rat heart from oxidative stress by exogenous creatine phosphate. J Mol Cell Cardiol. 1989 Jan; 21(1): 67–73. https://doi.org/10.1016/0022-2828(89)91494-6. PMID: 2716067</mixed-citation><mixed-citation xml:lang="en">Zucchi R., Poddighe R., Limbruno U., et al. Protection of isolated rat heart from oxidative stress by exogenous creatine phosphate. J Mol Cell Cardiol. 1989 Jan; 21(1): 67–73. https://doi.org/10.1016/0022-2828(89)91494-6. PMID: 2716067</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Shopit A., Niu M., Wang H., et al. Protection of diabetes-induced kidney injury by phosphocreatine via the regulation of ERK/Nrf2/HO-1 signaling pathway. Life Sci. 2020 Feb 1; 242: 117248. https://doi.org/10.1016/j.lfs.2019.117248. Epub 2019 Dec 31. PMID: 31899224</mixed-citation><mixed-citation xml:lang="en">Shopit A., Niu M., Wang H., et al. Protection of diabetes-induced kidney injury by phosphocreatine via the regulation of ERK/Nrf2/HO-1 signaling pathway. Life Sci. 2020 Feb 1; 242: 117248. https://doi.org/10.1016/j.lfs.2019.117248. Epub 2019 Dec 31. PMID: 31899224</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Procházková D., Boušová I., Wilhelmová N. Antioxidant and prooxidant properties of flavonoids. Fitoterapia. 2011 Jun; 82(4): 513–523. https://doi.org/10.1016/j.fitote.2011.01.018. Epub 2011 Jan 28. PMID: 21277359</mixed-citation><mixed-citation xml:lang="en">Procházková D., Boušová I., Wilhelmová N. Antioxidant and prooxidant properties of flavonoids. Fitoterapia. 2011 Jun; 82(4): 513–523. https://doi.org/10.1016/j.fitote.2011.01.018. Epub 2011 Jan 28. PMID: 21277359</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Bradic J., Jeremic N., Petkovic A., et al. Cardioprotective effects of Galium verum L. extract against myocardial ischemia-reperfusion injury. Arch Physiol Biochem. 2020 Dec; 126(5): 408–415. https://doi.org/10.1080/13813455.2018.1551904. Epub 2019 Jan 11. PMID: 30632812</mixed-citation><mixed-citation xml:lang="en">Bradic J., Jeremic N., Petkovic A., et al. Cardioprotective effects of Galium verum L. extract against myocardial ischemia-reperfusion injury. Arch Physiol Biochem. 2020 Dec; 126(5): 408–415. https://doi.org/10.1080/13813455.2018.1551904. Epub 2019 Jan 11. PMID: 30632812</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Penna C., Mancardi D., Rastaldo R., Pagliaro P. Cardioprotection: a radical view Free radicals in pre and postconditioning. Biochim Biophys Acta. 2009 Jul; 1787(7): 781–793. https://doi.org/10.1016/j.bbabio.2009.02.008. Epub 2009 Feb 24. PMID: 19248760</mixed-citation><mixed-citation xml:lang="en">Penna C., Mancardi D., Rastaldo R., Pagliaro P. Cardioprotection: a radical view Free radicals in pre and postconditioning. Biochim Biophys Acta. 2009 Jul; 1787(7): 781–793. https://doi.org/10.1016/j.bbabio.2009.02.008. Epub 2009 Feb 24. PMID: 19248760</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
